Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Invested Capital (2016 - 2025)

Rockwell Medical's Invested Capital history spans 16 years, with the latest figure at $37.8 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 10.66% year-over-year to $37.8 million; the TTM value through Dec 2025 reached $37.8 million, up 10.66%, while the annual FY2025 figure was $37.8 million, 10.66% up from the prior year.
  • Invested Capital reached $37.8 million in Q4 2025 per RMTI's latest filing, roughly flat from $37.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $37.9 million in Q3 2025 to a low of -$1.8 million in Q1 2022.
  • Average Invested Capital over 5 years is $23.7 million, with a median of $23.3 million recorded in 2022.
  • Peak YoY movement for Invested Capital: tumbled 106.67% in 2022, then surged 919.19% in 2023.
  • A 5-year view of Invested Capital shows it stood at $23.1 million in 2021, then increased by 0.74% to $23.3 million in 2022, then rose by 0.31% to $23.4 million in 2023, then skyrocketed by 45.93% to $34.1 million in 2024, then increased by 10.66% to $37.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Invested Capital are $37.8 million (Q4 2025), $37.9 million (Q3 2025), and $31.6 million (Q2 2025).